USA flag logo/image

An Official Website of the United States Government

SBIR TOPIC 252 - FUNCTIONALIZED BIMAGNETIC CORE/SHELL FE/FE3O4 STEALTH…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
94177
Program Year/Program:
2008 / SBIR
Agency Tracking Number:
N43CO0800059
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
NanoScale Materials, Inc.
1310 Research Park Drive Manhattan, KS -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2008
Title: SBIR TOPIC 252 - FUNCTIONALIZED BIMAGNETIC CORE/SHELL FE/FE3O4 STEALTH NANOPARTIC
Agency: HHS
Contract: N43CO0800059
Award Amount: $150,000.00
 

Abstract:

Early diagnosis and early treatment of cancer greatly improve the likelihood of long-term survival and health. Chemical structures that are selectively taken by cancerous tissue can be used to pull diagnostic and therapeutic moieties to cancerous tissue. A ppropriately sized iron and/or iron oxide nanoparticles are effective for both diagnosis (via magnetic resonance imaging, MRI) and therapy (by hyperthermal methods). But they tend to clump into ineffective sizes, and they distribute among healthy tissue, m aking them of little value for diagnosis or treatment. NanoScale Corporation, with its partners at Kansas State University, propose synthesis of "stealth" Fe/Fe3O4 core/shell nanoparticles that are encapsulated, to prevent agglomeration, and that contain c arefully selected functional groups that will localize in cancer tissues. The team will evaluate these stealth nanoparticles for physical properties such as MRI relaxivity and hyperthermal potential, and for adhesion to cancer cells. Finally, in vivo exper iments with tumor-bearing mice will confirm the feasibility of stealth Fe/Fe3O4 core/shell nanoparticles for cancer diagnosis and treatment. NanoScale has extensive experience in synthesis, manufacture, and characterization of metal and metal oxide nanopar ticles. Prof. Stefan Bossman is internationally recognized for his accomplishments in linking diagnostic and therapeutic groups to bioactive structures.

Principal Investigator:

Frank Kroh

Business Contact:


srajagopalan@nanoactive.com
Small Business Information at Submission:

NANOSCALE MATERIALS, INC.
NANOSCALE MATERIALS, INC. 1310 RESEARCH PARK DR MANHATTAN, KS 66502

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No